| 000 | 01121 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250513080005.0 | ||
| 264 | 0 | _c19930226 | |
| 008 | 199302s 0 0 eng d | ||
| 022 | _a0007-1250 | ||
| 024 | 7 |
_a10.1192/bjp.162.1.38 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDavies, L M | |
| 245 | 0 | 0 |
_aAssessment of costs and benefits of drug therapy for treatment-resistant schizophrenia in the United Kingdom. _h[electronic resource] |
| 260 |
_bThe British journal of psychiatry : the journal of mental science _cJan 1993 |
||
| 300 |
_a38-42 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aClozapine _xeconomics |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 650 | 0 | 4 | _aUnited Kingdom |
| 700 | 1 | _aDrummond, M F | |
| 773 | 0 |
_tThe British journal of psychiatry : the journal of mental science _gvol. 162 _gp. 38-42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1192/bjp.162.1.38 _zAvailable from publisher's website |
| 999 |
_c8424409 _d8424409 |
||